Market Summary
Equities are firmly higher at midday on Monday, September 21, with mega-cap technology and semiconductor names driving a broad-based rally. The S&P 500 has climbed 85.22 points (+1.11%) to 7735.72, the Nasdaq Composite has surged 454.37 points (+1.71%) to 26997.96, and the Dow Jones Industrial Average has added 232.52 points (+0.45%) to 51915.16. The session’s tone was set well before the opening bell, as a pullback in crude oil prices and a corresponding relief rally in sovereign bonds offset weekend geopolitical concerns, including a Houthi attack on Riyadh and President Trump’s early departure from Camp David.
Leadership remains concentrated in growth: Communication Services, Information Technology, Consumer Discretionary, and Real Estate are the standout sectors, while Energy and Consumer Staples lag as oil prices retreat. Meta Platforms is a standout gainer on optimism around its new AI agent “Muse,” while Intel and AMD are posting double-digit percentage gains amid a broader semiconductor rally. The debate over the pace of AI development remains a focal point, with President Trump and NVIDIA CEO Jensen Huang both pushing back against calls for a development slowdown.
Beneath the surface, participation is mixed — NYSE advancers lead decliners 1558 to 1029, and Nasdaq advancers lead 2664 to 1492, but WaveFinder’s broader breadth metrics show only 58% of stocks above their 20-day moving average and just 24.01% above their 40-day moving average, with Primary Sentiment reading “Very Bearish.” This divergence suggests today’s advance remains narrowly led by mega-cap and AI-adjacent names even as the major indices post strong headline gains.
Market Snapshot
| Index | Level | Change | % Change |
|—|—|—|—|
| Dow Jones | 51,915.16 | +232.52 | +0.45% |
| Nasdaq Composite | 26,997.96 | +454.37 | +1.71% |
| S&P 500 | 7,735.72 | +85.22 | +1.11% |
Breadth (NYSE): Advancers 1,558 | Decliners 1,029 | Volume 228.20 mln
Breadth (Nasdaq): Advancers 2,664 | Decliners 1,492 | Volume 4.45 bln
WaveFinder Breadth Metrics:
- Primary Sentiment: Very Bearish (Bulls 829 | Bears 912)
- 4% Sentiment: Bullish (Bulls 104 | Bears 26)
- 40 SMA Sentiment: Neutral
- % of Stocks Above 20-day SMA: 58%
- % of Stocks Above 40-day SMA: 24.01%
- 9-Month Bulls: 22 | Bears: 1 (Follow-Through: 56%)
Sector Performance
Ranked by available performance data (Briefing.com Industry Watch commentary and WaveFinder ATR readings):
1. Communication Services — Strong; +3.2% intraday (ATR 0.60%, falling, P32) — led by Meta Platforms’ surge
2. Information Technology — Strong; +1.6% intraday (ATR 0.57%, falling, P95) — semiconductor rally
3. Health Care — +0.7%, outperforming defensive peers (ATR 1.72%, rising, P42) — Moderna and biotech strength offsetting Novo Nordisk weakness
4. Consumer Discretionary — Strong per Industry Watch (ATR -1.86%, falling, P16)
5. Real Estate — Strong per Industry Watch (ATR -2.73%, flat, P16)
6. Financials — Not specifically quantified today (ATR -0.92%, falling, P16)
7. Materials — Not specifically quantified today (ATR -1.66%, falling, P0)
8. Industrials — Not specifically quantified today (ATR -2.06%, flat, P16)
9. Consumer Staples — Weak; -0.4% (ATR -1.31%, flat, P11)
10. Utilities — -0.1% (ATR -3.31%, falling, P5)
11. Energy — Weak per Industry Watch, pressured by 3.8% drop in WTI crude (ATR -0.41%, falling, P0)
Key Earnings & Movers
- Meta Platforms (META) — $712.82, +$47.60 (+7.16%): Rallying on positive investor response to its new personal AI agent, “Muse,” which reached the #1 spot on the App Store following launch and drew multiple brokerage upgrades.
- Intel (INTC) — $124.10, +$15.50 (+14.27%): Among the top S&P 500 performers amid broad semiconductor strength.
- AMD — $611.46, +$51.64 (+9.22%): Riding the same semiconductor rally as Intel.
- NVIDIA (NVDA) — $225.07, +$2.80 (+1.26%): Gaining as CEO Jensen Huang publicly dismissed AI safety concerns over the weekend.
- Moderna (MRNA) — $167.90, +$13.86 (+8.99%): Sharp gain supporting broader biotech strength.
- Novo Nordisk (NVO) — $39.76, -$3.48 (-8.06%): Sliding after Capital Markets Day guidance failed to ease patent-expiration and pricing concerns (see Spotlight below).
- Warner Bros. Discovery (WBD) — $30.58, +$2.78 (+9.98%): Surging after Paramount Skydance’s acquisition cleared a legal hurdle via a state settlement.
- Paramount Skydance (PSKY) — $10.81, +$0.60 (+5.90%): Gaining alongside WBD on the same settlement news.
- Alphabet (GOOG) — $348.92, +$4.50 (+1.31%): Firm amid broader mega-cap tech strength.
- New Era Energy & Digital (NUAI) — +29%: Surging on a 20-year power purchase agreement with Vistra’s Luminant subsidiary for its Texas data center project.
Stock Spotlight
Novo Nordisk (NVO): Long-Term Targets Fail to Quiet Patent and Pricing Fears
Novo Nordisk shares are down sharply (-8.06% to $39.76) after the company’s Capital Markets Day outlined 2026-2030 revenue growth expectations broadly in line with the global pharmaceutical market — guidance investors viewed as underwhelming given looming semiconductor… rather, semaglutide patent expirations and mounting pricing pressure. While NVO targets more than five product launches with multi-blockbuster potential by 2030 and over DKK 150 billion in annual pipeline sales potential by 2035, these remain strategic ambitions contingent on clinical, regulatory, and commercial execution rather than formal guidance.
Favorable Phase III CagriSema data provided a partial offset: the REIMAGINE 5 trial showed CagriSema (1.0mg/1.0mg) delivering 12.4% weight loss versus 9.1% for tirzepatide 5mg, and REDEFINE 9 showed roughly 21% weight loss at the higher 1.7mg/1.7mg dose versus 2% for placebo. However, these results don’t fully resolve competitive positioning questions, particularly following CagriSema’s earlier high-dose failure to beat tirzepatide 15mg in REDEFINE 4. Adding to the overhang, Canada has approved generic semaglutide products for type 2 diabetes — an early signal of the pricing erosion NVO may face as patent protections lapse in larger markets — while 13,000 planned workforce departures highlight the scale of restructuring needed to fund new launches. A U.S. regulatory decision on CagriSema for weight management is expected in Q4, with a potential early-2027 launch representing the next key catalyst.
Bond Market & Treasuries
Treasury yields are lower across the curve at midday as oil’s decline continues to drive a relief trade in sovereign bonds, though the overnight rally has lost some momentum.
Yield Check (as of 11:07 ET):
- 2-yr: 4.74% (unchanged)
- 3-yr: 4.81% (-2 bps)
- 5-yr: 4.83% (-3 bps)
- 10-yr: 4.97-4.98% (-3 bps)
- 30-yr: 5.30% (-3 bps)
Key Drivers: With no U.S. economic data on the calendar today, the bond market’s primary catalyst has been the pullback in crude oil. Chicago Fed President Austan Goolsbee (non-voter) noted in a speech that persistent supply shocks may require further Fed action on inflation. Trading catalysts remain thin heading into Tuesday, though a $69 billion 2-year note auction is on deck.
Commodities
- WTI Crude Oil: $96.51/bbl, -3.8% (per latest intraday update; down from $97.28 pre-market and $101.23 Friday close)
- Brent Crude: $101.27/bbl, -2.6% (morning reading)
- Gold: $4,398.80/ozt, -0.6% (overnight reading)
- Copper: $6.81/lb, +1.8% (overnight reading)
Oil’s decline is the session’s dominant cross-asset theme, tied to reports that Saudi Arabia exported nearly 3.0 million barrels per day through the Strait of Hormuz over the past six days and rising hope for a diplomatic breakthrough between the U.S. and Iran around this week’s UN General Assembly meetings.
Overseas Markets
Specific Asian and European index levels were not provided in today’s data set. Currency markets show USD/JPY at 157.46 and EUR/USD at 1.1472 as of the midday bond update. Geopolitical developments remain the key overseas driver: optimism is building ahead of the September 24 Trump-Xi summit in Washington, following what Treasury Secretary Bessent called a “successful” weekend meeting with China’s Vice Premier He Lifeng. Separately, President Trump announced a deal with Denmark and Greenland granting the U.S. a significant military presence on the island.
Economic Data
There is no U.S. economic data of note scheduled for release today (Yom Kippur). Market direction has instead been driven entirely by oil prices, Treasury yields, and geopolitical headlines.
Looking Ahead
- Tuesday, Sept 22: $69 billion 2-year Treasury note auction; no significant U.S. economic data scheduled.
- Tuesday, Sept 22: President Trump is scheduled to meet with Ukrainian President Volodymyr Zelensky in New York.
- Thursday, Sept 24: Trump-Xi summit in Washington, D.C. — a key catalyst for U.S.-China trade sentiment.
- This week: Potential Trump-Iran presidential meeting on the sidelines of the UN General Assembly, which markets are watching closely for de-escalation signals.
- Pending: President Trump has indicated an upcoming announcement of an AI “Czar.”
- Continued focus on semiconductor and AI-infrastructure stock volatility following recent sharp swings in the group.